Stock comparison
Merck & Co., Inc. is 77.4x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($371.29 B vs $4.80 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 77.4x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($371.29 B vs $4.80 B).
Market value leader
MRK
Merck & Co., Inc. is 77.4x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($371.29 B vs $4.80 B).
Revenue leader
MRK
ACAD: $1.07B vs MRK: $65.01B.
Profit leader
MRK
ACAD: $391.00M vs MRK: $18.25B.
Margin leader
ACAD
ACAD: 36.5% vs MRK: 28.1% net margin.
| Metric | ACAD | MRK |
|---|---|---|
| Market cap | $4.80 B | $371.29 B |
| US-listed rank | #1453 | #34 |
| Revenue (latest FY) | $1.07B | $65.01B |
| Net income (latest FY) | $391.00M | $18.25B |
| Net margin | 36.5% | 28.1% |
| P/E (trailing FY) | 12.3x | 20.3x |
| SEC filings | 1,357 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 77.4x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($371.29 B vs $4.80 B).
In their latest fiscal years, ACADIA PHARMACEUTICALS INC reported $1.07B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ACADIA PHARMACEUTICALS INC and Merck & Co., Inc., or browse the full rankings.